$NEOG

NEOGEN CORP

Neogen develops, manufactures and markets products and services for food and animal safety. Its Food Safety segment sells diagnostic test kits, culture media, pathogen detection systems, sample collection products and food safety software to food and feed producers, processors, laboratories and regulatory organizations. The products detect contaminants and help assess food quality and hygiene. Neogen Analytics aggregates and tracks testing and sanitation data. Its Animal Safety segment serves livestock producers, veterinarians, researchers and companion animal owners with veterinary instruments, pharmaceuticals, vaccines, diagnostic products, animal care products, rodent and insect controls, and genomics testing services. Products are sold through Neogen’s sales personnel and distributors, as well as through veterinarians, retailers and animal health distributors. Neogen operates in the United States and internationally, and is headquartered in Lansing, Michigan.

AlphAI earnings readQ1 FY27 · OCT 6Neogen Reports First-Quarter Financial Results for Fiscal Year 2027Verdict: solid

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

0
1
0
—
$115K
Yarwood Jeremy
0%
See all $NEOG insider activity →
Low

Better Than Expected Results Lifted Neogen Corporation (NEOG) Higher in Q3

Baron Capital's Q3 2026 investor letter reported a 7.69% decline in its Small Cap Fund, outperforming the Russell 2000 Growth Index. Neogen Corporation (NEOG), a food and animal safety solutions provider, contributed 0.67% to returns, with shares rising due to better-than-expected Q4 results, including organic growth, margin expansion, and high free cash flow. NEOG closed at $11.60 per share, down 5.25% over the past month but up 75.12% over 52 weeks.

Neogen Chemicals secures GPCB consent for Dahej plant operations

Neogen Chemicals received regulatory approval from the Gujarat Pollution Control Board to resume operations at its Dahej facility, which was halted after a 2025 fire. The approval allows the company to operate a new plant (MPP-5) and is valid until 2030. The company also disclosed a minor insider share sale by a director's family entity.

Neogen Chemicals Limited Faces Rs 34.60 Lakh GPCB Cost Order

Neogen Chemicals (NCL) was ordered by GPCB to halt operations at its fire-damaged Dahej SEZ facilities until approvals are received. The company faces a Rs 34.60 lakh environmental damage cost and must submit a Rs 7.5 lakh bank guarantee. Reconstruction may take 9-12 months, but revenue guidance remains unchanged.

NEOG sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning NEOG (NEOGEN CORP). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent NEOG coverage spans earnings, regulation and insider activity.

In the last 30 days, NEOG insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($115K). The most active reporter was Yarwood Jeremy, Chief Scientific Officer, with 1 filing.

What's driving NEOG

  • Recap of already‑priced earnings; no new catalyst.

    finance.yahoo.com · Nov 13, 2026

  • Neogen Chemicals received regulatory approval from the Gujarat Pollution Control Board to resume operations at its Dahej facility, which was halted after a 2025 fire. The approval allows the company to operate a new plant (MPP-5) and is valid until 2030. The company also disclosed a minor insider share sale by a director's family entity.

    scanx.trade · Nov 8, 2026

  • Neogen Chemicals (NCL) was ordered by GPCB to halt operations at its fire-damaged Dahej SEZ facilities until approvals are received. The company faces a Rs 34.60 lakh environmental damage cost and must submit a Rs 7.5 lakh bank guarantee. Reconstruction may take 9-12 months, but revenue guidance remains unchanged.

    multibagg.ai · Nov 8, 2026

  • Insider sale may signal reduced confidence and could weigh on the stock.

    SEC EDGAR · Nov 4, 2026

  • Neogen Chemicals (BOM:542665) reported Q2 2027 earnings, with a 42% revenue surge. The company guided FY27 battery chemicals revenue at INR 250-300 crore and FY28 at over INR 1,000 crore. Base chemicals guidance for FY27 was upgraded to over INR 1,100 crore. Net debt for FY28 is expected to be INR 1,300-1,500 crore. The company is benefiting from US demand shifts due to tax credits and has secured customer approvals for lithium electrolyte salts.

    finance.yahoo.com · Nov 4, 2026

AlphAI scores every news story that mentions NEOG with an AI model for sentiment and relevance, and aggregates insider trades from NEOGEN CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $NEOG

Score

Better Than Expected Results Lifted Neogen Corporation (NEOG) Higher in Q3

Baron Capital's Q3 2026 investor letter reported a 7.69% decline in its Small Cap Fund, outperforming the Russell 2000 Growth Index. Neogen Corporation (NEOG), a food and animal safety solutions provider, contributed 0.67% to returns, with shares rising due to better-than-expected Q4 results, including organic growth, margin expansion, and high free cash flow. NEOG closed at $11.60 per share, down 5.25% over the past month but up 75.12% over 52 weeks.

Neogen Chemicals secures GPCB consent for Dahej plant operations

Neogen Chemicals received regulatory approval from the Gujarat Pollution Control Board to resume operations at its Dahej facility, which was halted after a 2025 fire. The approval allows the company to operate a new plant (MPP-5) and is valid until 2030. The company also disclosed a minor insider share sale by a director's family entity.

Neogen Chemicals Limited Faces Rs 34.60 Lakh GPCB Cost Order

Neogen Chemicals (NCL) was ordered by GPCB to halt operations at its fire-damaged Dahej SEZ facilities until approvals are received. The company faces a Rs 34.60 lakh environmental damage cost and must submit a Rs 7.5 lakh bank guarantee. Reconstruction may take 9-12 months, but revenue guidance remains unchanged.

Neogen Chemicals Ltd (BOM:542665) (Q2 2027) Earnings Call Highlights: 42% Revenue

Neogen Chemicals (BOM:542665) reported Q2 2027 earnings, with a 42% revenue surge. The company guided FY27 battery chemicals revenue at INR 250-300 crore and FY28 at over INR 1,000 crore. Base chemicals guidance for FY27 was upgraded to over INR 1,100 crore. Net debt for FY28 is expected to be INR 1,300-1,500 crore. The company is benefiting from US demand shifts due to tax credits and has secured customer approvals for lithium electrolyte salts.

$NEOGHighM&A· definitive

Neogen Corporation announced that it had entered into a definitive agreement to sell its global Genomics business to Zoetis Inc

NEOGEN CORP (NEOG) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On March 2, 2026, Neogen Corporation (“ Neogen ”) announced that it had entered into a definitive agreement to sell its global Genomics business to Zoetis Inc. (“ Zoetis ”). This transaction is subject to customary closing conditions and regulatory approva

Neogen Chemicals approves material related party transactions up to ₹500 crore

Neogen Chemicals' board approved material related party transactions up to ₹500 crore with its subsidiary, Neogen Morita New Materials. They also increased the threshold for loans, ICDs, and guarantees to ₹500 crore. The board reviewed unaudited financial results for Q3 and H1 2026, confirming no deviation in QIP funds usage. They approved a ₹45 crore expansion of its Organo-Lithium facility and early redemption of ₹200 crore NCDs.

Up 64% in 6 months already; should you still buy Neogen Chemicals? Antique sees 23% upside potential - Check target

Antique Stock Broking initiated coverage on Neogen Chemicals with a Buy rating and a target price of Rs.3,050, implying a 23% upside. The brokerage expects strong earnings growth driven by battery chemicals, with revenue, EBITDA, and PAT growing at CAGRs of 45%, 49%, and 87% respectively from FY26 to FY30. The stock has surged 64% in 6 months but faces execution and debt management risks.

Related tickers